Clinical study of anti-inflammatory and analgesic effect of Baxo (piroxicam) in treatment of diseases and post-operative cases in oral surgery.
スポンサーリンク
概要
- 論文の詳細を見る
We administered Baxo (generic name: piroxicam) to 32 patients with inflammation or pain caused by inflammatory or painful diseases, or caused by operations including tooth extraction, treated at the Department of Dentistry and Oral Surgery, Medical College of Oita, between Mar. to Dec., 1983. We examined its anti-inflammatory and analgesic effect, and gained the following results.<BR>1) To 13 patients with inflammatory or painful diseases and 12 patients operated, Baxo 20 mg each once daily, per os, was added for 3 days to 6 weeks except one case stopped within only 2 days because of side effect. To 7 patients undegone for minor surgery, Baxo 20 mg was added at pain time.<BR>2) In all cases, the results were divided into seven classes, and the ratio of remarkable improvement was 43.8% (14/32), the moderate improvement 28.1% (9/32), and the ratio of both gathered 71.9% (23/32) .<BR>3) The ratio of its remarkable usefulness was 31.1% (10/32), the usefulness 37.5% (12/32), and the ratio of both 68.8% (22/32) .<BR>4) The side effects were observed in two cases out of 32 cases (6.3%) . One case was edema of leg and face, the other was diarrhea, of which both were soonly disappeared by withdrawal of Baxo and concomitant antibiotics.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果